
6:30–7:45 am
CME/CE NOT APPLICABLE
This session will review controversies and issues surrounding the diagnosis of ductal carcinoma in situ (DCIS) in patients. It will present data comparing molecular tools with clinicopathologic features in assessing the risk of local recurrence for DCIS patients and describe the clinical implications for risk assessment of DCIS.
Speaker: Sunil Badve, MD